Kenvue Inc., the maker of Tylenol, saw its shares drop following a Wall Street Journal report suggesting a potential link between acetaminophen (Tylenol's active ingredient) and autism. The report, citing unnamed sources, claims an upcoming government report will indicate a possible connection. However, the Health and Human Services Secretary stated the report was speculative, and the government's official findings are due this month.
Prepared by Christopher Adams and reviewed by editorial team.
Comments